Scholar Rock Holding Corp
SRRK- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001727196
In the last 90 days, Scholar Rock Holding Corp insiders filed 0 open-market purchases and 5 sales; 306 institutions reported holding it in 13F filings for Q2 2026, worth $7.63B in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Scholar Rock Holding Corp as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 274
- +6 vs. Q4 2025
- Shares held
- 132.8M
- +16.6M (+14.3%) vs. Q4 2025
- Total value
- $6.53B
- +$1.41B (+27.5%) vs. Q4 2025
- New holders
- 41
- 113 more added
- Sold out
- 35
- 78 more reduced
6 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRRK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 306 | $7.63B |
| Q1 2026 | 274 | $6.53B |
| Q4 2025 | 274 | $5.44B |
| Q3 2025 | 241 | $4.32B |
| Q2 2025 | 236 | $3.89B |
| Q1 2025 | 231 | $3.42B |
| Q4 2024 | 224 | $4.51B |
| Q3 2024 | 161 | $710.2M |
| Q2 2024 | 166 | $712.1M |
| Q1 2024 | 161 | $1.51B |
| Q4 2023 | 133 | $1.52B |
| Q3 2023 | 89 | $382.7M |
| Q2 2023 | 85 | $386.3M |
| Q1 2023 | 87 | $374.1M |
| Q4 2022 | 82 | $410.2M |
| Q3 2022 | 85 | $313.1M |
| Q2 2022 | 83 | $248.6M |
| Q1 2022 | 94 | $402.2M |
| Q4 2021 | 90 | $738.8M |
| Q3 2021 | 101 | $952.5M |
| Q2 2021 | 105 | $825.5M |
| Q1 2021 | 124 | $1.41B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Scholar Rock Holding Corp; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −296−100.0% | Sold out |
| Garner Asset Management Corp | 0 | $0 | 0.00% | −140−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Sunbelt Securities, Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Accent Capital Management, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Hughes Financial Services, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Norges Bank | – | – | – | – | Not filed |
| Clarius Group, LLC | – | – | – | – | Not filed |
| CIBC World Markets Corp | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |